Exelixis
EXEL
#1704
Rank
A$15.51 B
Marketcap
$54.33
Share price
-0.65%
Change (1 day)
53.70%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Stock price history for Exelixis (EXEL)

Highest end of day price: $79.14 AUD on 2000-07-26

Lowest end of day price: $2.07 AUD on 2014-12-24

Stock price history of Exelixis from 2000 to 2024

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
$54.76-0.12%๐Ÿ‡ฌ๐Ÿ‡ง UK
$78.31 0.62%๐Ÿ‡ซ๐Ÿ‡ท France
$160.21-0.17%๐Ÿ‡บ๐Ÿ‡ธ USA
$92.69-0.55%๐Ÿ‡บ๐Ÿ‡ธ USA
$422.06-0.20%๐Ÿ‡บ๐Ÿ‡ธ USA
$233.09-0.36%๐Ÿ‡บ๐Ÿ‡ธ USA
$42.78 0.23%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.22 3.50%๐Ÿ‡บ๐Ÿ‡ธ USA
$24.10 0.00%๐Ÿ‡บ๐Ÿ‡ธ USA